{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:16:46Z","timestamp":1767143806043,"version":"build-2238731810"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-023-00833-3","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T05:02:23Z","timestamp":1700715743000},"page":"233-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional changes in the heart after sacubitril\/valsartan use in 5 hemodialysis patients with hypertension. Case report"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2415-4234","authenticated-orcid":false,"given":"Noriko","family":"Kuwae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"833_CR1","unstructured":"JSDT. http:\/\/www.jsdt.or.jp\/info\/4032.html.online. Accessed 2021"},{"key":"833_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42:681\u20133. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1012.","journal-title":"Eur Heart J"},{"key":"833_CR3","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ehf2.12544","volume":"6","author":"A Heyse","year":"2019","unstructured":"Heyse A, Manhaeghe L, Mahieu E, Vanfraechem C, Van Durme F. Sacubitril\/valsartan in heart failure and end-stage renal insufficiency. ESC Heart Fail. 2019;6:1331\u20133. https:\/\/doi.org\/10.1002\/ehf2.12544.","journal-title":"ESC Heart Fail"},{"key":"833_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ehf2.12659","volume":"7","author":"S Lee","year":"2020","unstructured":"Lee S, Oh J, Kim H, Ha J, Chun KH, Lee CJ, Park S, Lee SH, Kang SM. Sacubitril\/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease. ESC Heart Fail. 2020;7:1125\u20139. https:\/\/doi.org\/10.1002\/ehf2.12659.","journal-title":"ESC Heart Fail"},{"key":"833_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000029186","volume":"101","author":"Y Feng","year":"2022","unstructured":"Feng Y, Li W, Liu H, Chen X. Low dose sacubitril\/valsartan is effective and safe in hemodialysis patient with decompensated heart failure and hypotension: a case report. Medicine (Baltimore). 2022;101: e29186. https:\/\/doi.org\/10.1097\/md.0000000000029186.","journal-title":"Medicine (Baltimore)"},{"key":"833_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.52547\/ijkd.5875","volume":"15","author":"W Lihua","year":"2021","unstructured":"Lihua W, Cheng L, Chen H, Wei F, Jiang A. Use of angiotensin receptor neprilysin inhibitor in patients on maintenance hemodialysis with reduced cardiac ejection fraction, real-world experience from a single center. Iran J Kidney Dis. 2021;15:288\u201399. https:\/\/doi.org\/10.52547\/ijkd.5875.","journal-title":"Iran J Kidney Dis"},{"key":"833_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4236\/crcm.2021.107025","volume":"10","author":"P Kong","year":"2021","unstructured":"Kong P, Dou Y, Wang X, Xiao J, Zhao Z. The effect of sacubitril\/valsartan in a dialysis patient with severe heart failure. Case Rep Clin Med. 2021;10:197\u2013202. https:\/\/doi.org\/10.4236\/crcm.2021.107025.","journal-title":"Case Rep Clin Med"},{"key":"833_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/1744-9987.13715","volume":"26","author":"S Daimon","year":"2021","unstructured":"Daimon S, Yasuda M, Maeda K. Effect of sacubitril\/valsartan on cardiac function in hemodialysis patients. Ther Apher Dial. 2021;26:244\u20135. https:\/\/doi.org\/10.1111\/1744-9987.13715.","journal-title":"Ther Apher Dial"},{"key":"833_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/jch.14635","volume":"25","author":"Y Iwashima","year":"2023","unstructured":"Iwashima Y, Fukushima H, Horio T, Rai T, Ishimitsu T. Efficacy and safety of sacubitril\/valsartan after switching from azilsartan in hemodialysis patients with hypertension. J Clin Hypertens (Greenwich). 2023;25:304\u20138. https:\/\/doi.org\/10.1111\/jch.14635.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"833_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41100-023-00473-4","volume":"9","author":"S Daimon","year":"2023","unstructured":"Daimon S, Sakamoto Y, Yasuda M, Nishitani M. Long-term cardiac effect of sacubitril-valsartan in hemodialysis patients with a reduced ejection fraction after aortic valve replacement for aortic stenosis: a case report with literature review. Ren Replace Ther. 2023;9:19. https:\/\/doi.org\/10.1186\/s41100-023-00473-4.","journal-title":"Ren Replace Ther"},{"key":"833_CR11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ejhf.799","volume":"19","author":"E D\u2019Elia","year":"2017","unstructured":"D\u2019Elia E, Iacovoni A, Vaduganathan M, Lorini FL, Perlini S, Senni M. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. Eur J Heart Fail. 2017;19:710\u20137. https:\/\/doi.org\/10.1002\/ejhf.799.","journal-title":"Eur J Heart Fail"},{"key":"833_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077.","journal-title":"N Engl J Med"},{"key":"833_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2019.12821","volume":"322","author":"JL Januzzi Jr","year":"2019","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Pi\u00f1a IL, Rocha RA, Shah AM, Williamson KM, Solomon SD. Association of change in N-Terminal Pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA. 2019;322:1085\u201395. https:\/\/doi.org\/10.1001\/jama.2019.12821.","journal-title":"JAMA"},{"key":"833_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jchf.2020.09.013","volume":"9","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Prescott MF, Camacho A, Iyer SR, Maisel AS, Felker GM, Butler J, Pi\u00f1a IL, Ibrahim NE, Abbas C, Burnett JC Jr, Solomon SD, Januzzi JL. Atrial natriuretic peptide and treatment with sacubitril\/valsartan in heart failure with reduced ejection fraction. JACC Heart Fail. 2020;9:127\u201336. https:\/\/doi.org\/10.1016\/j.jchf.2020.09.013.","journal-title":"JACC Heart Fail"},{"key":"833_CR15","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1373\/clinchem.2004.035741","volume":"50","author":"FS Apple","year":"2004","unstructured":"Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type peptide, high sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem. 2004;50:2279\u201385.","journal-title":"Clin Chem"},{"key":"833_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, B\u00f6hm M, Butler J, Drazner MH, Michael FG, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco PM, Ponikowski P, Rosano GMC, Sakata Y, Seferovi\u0107 P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and New Zealand, and Chinese heart failure association. Eur J Heart Fail. 2021;23:352\u201380. https:\/\/doi.org\/10.1002\/ejhf.2115.","journal-title":"Eur J Heart Fail."},{"key":"833_CR17","first-page":"633","volume":"53","author":"T Naito","year":"2011","unstructured":"Naito T, Masaki T, Shimizu Y, Ogawa T, Ochiai M, Hamaguchi N, Hirashio S, Doi T, Yokoyama Y, Yorioka N. N-terminal pro brain natriuretic peptide predicts hospitalization of hemodialysis patients for cardiovascular disease. Nihon Jinzo Gakkai Shi. 2011;53:633\u201341.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"833_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/s0002-9149(02)02864-3","volume":"90","author":"TS Tsang","year":"2002","unstructured":"Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284\u20139. https:\/\/doi.org\/10.1016\/s0002-9149(02)02864-3.","journal-title":"Am J Cardiol"},{"key":"833_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/circulationaha.119.044586","volume":"141","author":"SD Solomon","year":"2020","unstructured":"Solomon SD, Vaduganathan M, Claggett BL, Packer M, Zile M, Swedberg K, Rouleau J, Pfeffer MA, Desai A, Lund LH, Kober L, Anand I, Sweitzer N, Linssen G, Merkely B, Arango JL, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV. Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure. Circulation. 2020;141:352\u201361. https:\/\/doi.org\/10.1161\/circulationaha.119.044586.","journal-title":"Circulation"},{"key":"833_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000519643","volume":"51","author":"Z Feng","year":"2021","unstructured":"Feng Z, Wang X, Zhang L, Apaer R, Xu L, Ma J, Li X, Che H, Tang B, Xiong Y, Xia Y, Xiao J, Su X, Wang Y, Dou X, Chen J, Mei L, Xue Z, Kong Y, Li S, Zhang H, Lin T, Wen F, Fu X, Tao Y, Fu L, Li Z, Huang R, Ye Z, He C, Shi W, Liang X, Ke G, Liu S. Pharmacokinetics and pharmacodynamics of sacubitril\/valsartan in maintenance hemodialysis patients with heart failure. Blood Purif. 2021;51:270\u20139. https:\/\/doi.org\/10.1159\/000519643.","journal-title":"Blood Purif"},{"key":"833_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.877237","volume":"9","author":"L Gan","year":"2022","unstructured":"Gan L, Lyu X, Yang X, Zhao Z, Tang Y, Chen Y, Yao Y, Hong F, Xu Z, Chen J, Gu L, Mao H, Liu Y, Sun J, Zhou Z, Du X, Jiang H, Li Y, Sun N, Liang X, Zuo L. Application of angiotensin receptor-neprilysin inhibitor in chronic kidney disease patients: Chinese expert consensus. Front Med (Lausanne). 2022;9: 877237.","journal-title":"Front Med (Lausanne)"}],"updated-by":[{"DOI":"10.1007\/s13730-023-00844-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000}},{"DOI":"10.1007\/s13730-024-00899-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000}}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-023-00833-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:13:55Z","timestamp":1722492835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-023-00833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s13730-023-00833-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13730-023-00844-0","URL":"https:\/\/doi.org\/10.1007\/s13730-023-00844-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13730-024-00899-7","URL":"https:\/\/doi.org\/10.1007\/s13730-024-00899-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at the facility in which the studies were conducted (IRB approval number 2022 A-2) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}